A coronavirus vaccine developed by the Beijing Institute of Biological Products was granted conditional market approval in December. Photo: Xinhua A coronavirus vaccine developed by the Beijing Institute of Biological Products was granted conditional market approval in December. Photo: Xinhua
A coronavirus vaccine developed by the Beijing Institute of Biological Products was granted conditional market approval in December. Photo: Xinhua
China Society

Coronavirus: China’s Sinopharm seeks general use green light for second vaccine

  • State firm says it has applied for approval for shot developed by the Wuhan Institute of Biological Products
  • Work is also under way on a third jab using different technology that would be easier to scale up, company chairman says

Topic |   China Society
A coronavirus vaccine developed by the Beijing Institute of Biological Products was granted conditional market approval in December. Photo: Xinhua A coronavirus vaccine developed by the Beijing Institute of Biological Products was granted conditional market approval in December. Photo: Xinhua
A coronavirus vaccine developed by the Beijing Institute of Biological Products was granted conditional market approval in December. Photo: Xinhua
READ FULL ARTICLE